Acomplia (Rimonabant) - Investigational Agent for the Management of Obesity
Developed by Sanofi-Aventis, Acomplia (rimonabant) is a selective...
Erbitux (Cetuximab)
Erbitux is a chimaeric monoclonal antibody (MAb) that is specific for...
Tarceva - Small Molecule
Tarceva (erlotinib) is an oral anti-cancer drug developed by...
Exanta - Oral Direct Thrombin Inhibitor for the
Exanta (ximelagatran) is an oral Direct Thrombin Inhibitor (DTI)...
Capravirine - Anti-Retroviral Drug
Developed by Pfizer Global Research and Development, capravirine is...
See all projects
QGC commences Phase I study of blood pressure monitoring drug
Quantum Genomics (QGC) has begun the Phase I clinical study of its...
CSL Behring begins phase II/III haemophilia study
CSL Behring has initiated a global phase II/III, multi-centre study,...
Boston Therapeutics completes Sugardown blood sugar management trial
Boston Therapeutics has completed a trial evaluating the dietary...
Pharmacyclics and NCI Partner to Develop Blood Cancer Drug
Pharmacyclics has signed a five-year cooperative research and...
Regado Reports Positive Results from Anticoagulation Drug Study
Regado Biosciences has reported positive primary results from the Phase...
FDA Grants Fast-Track Development Status to Octapharma Coagulation Drug
The US Food and Drug Administration (FDA) has approved...
US Approves First Anticoagulant for Half a Century
Boehringer Ingelheim has received US Food and Drug Administration...
New Therapy Class Successful Against Blood Cancer
A first-in-class drug SNS-032, being tested by a team of industry...
Good Results for Investigational Anticoagulant Apixaban
Apixaban, an anticoagulant being jointly developed by Bristol-Myers...
Novartis Three-in-One Blood Pressure Drug Approved in EU
Novartis has been granted authorisation from the European Commission...
See all news
Twitter
Facebook